- Home
- DRRX vs JSPR Comparison
DRRX vs JSPR Comparison
Compare DRRX & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- JSPR
- Stock Information
- Founded
- DRRX 1998
- JSPR 2018
- Country
- DRRX United States
- JSPR United States
- Employees
- DRRX N/A
- JSPR N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRRX Health Care
- JSPR Health Care
- Exchange
- DRRX Nasdaq
- JSPR Nasdaq
- Market Cap
- DRRX 59.3M
- JSPR 47.6M
- IPO Year
- DRRX 2000
- JSPR N/A
- Fundamental
- Price
- DRRX $1.92
- JSPR $2.80
- Analyst Decision
- DRRX Hold
- JSPR Buy
- Analyst Count
- DRRX 1
- JSPR 12
- Target Price
- DRRX N/A
- JSPR $30.78
- AVG Volume (30 Days)
- DRRX 487.4K
- JSPR 215.8K
- Earning Date
- DRRX 08-12-2025
- JSPR 08-13-2025
- Dividend Yield
- DRRX N/A
- JSPR N/A
- EPS Growth
- DRRX N/A
- JSPR N/A
- EPS
- DRRX N/A
- JSPR N/A
- Revenue
- DRRX $1,657,000.00
- JSPR N/A
- Revenue This Year
- DRRX N/A
- JSPR N/A
- Revenue Next Year
- DRRX $673.00
- JSPR N/A
- P/E Ratio
- DRRX N/A
- JSPR N/A
- Revenue Growth
- DRRX N/A
- JSPR N/A
- 52 Week Low
- DRRX $0.48
- JSPR $2.27
- 52 Week High
- DRRX $2.64
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- DRRX 78.08
- JSPR 39.48
- Support Level
- DRRX $1.86
- JSPR $2.91
- Resistance Level
- DRRX $1.96
- JSPR $3.05
- Average True Range (ATR)
- DRRX 0.04
- JSPR 0.16
- MACD
- DRRX -0.04
- JSPR 0.05
- Stochastic Oscillator
- DRRX 60.00
- JSPR 37.04
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.